Press Highlights Archives

Archives

10-2009 (1 items)	6-2009 (5 items)	2-2009 (2 items)	10-2008 (3 items)
9-2009 (3 items)	5-2009 (3 items)	1-2009 (4 items)	9-2008 (4 items)
8-2009 (11 items)	4-2009 (6 items)	12-2008 (5 items)	6-2008 (3 items)
7-2009 (6 items)	3-2009 (7 items)	11-2008 (4 items)

"Drug Companies Rushing To File With FDA May Want To Reconsider"
On September 16, 2009, The Wall Street Journal cited Booz Allen's first-cycle review study for the Food & Drug Administration in an article about the surge in new drug applications at the end of each year.

"Industry Official: More Contractors Will Absorb Online Privacy Expenses"
On September 10, 2009, Nextgov.com cited Booz Allen's Lloyd Howell in an article about the need to develop trusted services.

"Report: Drug Companies Meeting Post-Approval Reporting Requirements"
On September 3, 2009, The Wall Street Journal cited a Booz Allen study that examined the backlog of industry postmarketing studies for FDA-approved drugs and biologics and found that most companies meet their obligations in a timely manner.